12/19
12:17 pm
imnn
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
12/19
08:43 am
imnn
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $29.00 price target on the stock.
Low
Report
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $29.00 price target on the stock.
12/19
08:15 am
imnn
IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer [Yahoo! Finance]
Low
Report
IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer [Yahoo! Finance]
12/19
08:05 am
imnn
IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer
Low
Report
IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer
12/11
08:21 am
imnn
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
12/10
09:44 am
imnn
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $29.00 price target on the stock.
Medium
Report
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $29.00 price target on the stock.
12/10
08:05 am
imnn
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
Low
Report
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
11/25
09:08 am
imnn
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $29.00 price target on the stock.
Medium
Report
Imunon, Inc. (NASDAQ: IMNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $29.00 price target on the stock.
12/19
04:15 pm
imnn
Form 4 Imunon, Inc. For: Dec 18 Filed by: Tardugno Michael H
High
Report
Form 4 Imunon, Inc. For: Dec 18 Filed by: Tardugno Michael H
11/27
04:31 pm
imnn
Form 8-K Imunon, Inc. For: Nov 26
Low
Report
Form 8-K Imunon, Inc. For: Nov 26
11/14
05:37 pm
imnn
Form SC 13G Imunon, Inc. Filed by: Ayrton Capital LLC
Low
Report
Form SC 13G Imunon, Inc. Filed by: Ayrton Capital LLC
11/14
12:18 pm
imnn
Form SC 13G/A Imunon, Inc. Filed by: CVI Investments, Inc.
Low
Report
Form SC 13G/A Imunon, Inc. Filed by: CVI Investments, Inc.
11/7
09:05 am
imnn
Form 8-K Imunon, Inc. For: Nov 07
High
Report
Form 8-K Imunon, Inc. For: Nov 07
11/7
09:01 am
imnn
Form 10-Q Imunon, Inc. For: Sep 30
High
Report
Form 10-Q Imunon, Inc. For: Sep 30
10/31
07:57 pm
imnn
Form 4/A Imunon, Inc. For: Sep 06 Filed by: Lindborg Stacy
Low
Report
Form 4/A Imunon, Inc. For: Sep 06 Filed by: Lindborg Stacy
10/8
04:40 pm
imnn
Form 4 Imunon, Inc. For: Oct 07 Filed by: Eylward Susan
Low
Report
Form 4 Imunon, Inc. For: Oct 07 Filed by: Eylward Susan
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register